A 10-year Survey of Clinically Significant Blood Culture Isolates and Antibiotic Susceptibilities from Adult Patients with Hematological Diseases at a Major Swedish Hospital

References

• Frøland SS. Bacterial infections in the compromised host. Scand J Infect Dis, Suppl 1984; 43: 7–16
   PubMedGoogle Scholar
• Johansson P JH, Ursing B. Infectious complications to granulocytopenia. Scand J Infect Dis 1984; 16: 361–367
   PubMedGoogle Scholar
• Bodey GP, Bolivar R, Fainstein V. Infectious complications in leukemic patients. Semin Hematol 1982; 19: 193–226
   PubMed Web of Science ®Google Scholar
• EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–1698
   PubMed Web of Science ®Google Scholar
• Klastersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis, Suppl 1983; 5: S21–31
   Google Scholar
• Schimpff SC. Overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis, Suppl 1985; 7: S734–740
   Google Scholar
• Pizzo PA, Commers J, Cotton D, Gress J, Hathorn J, Hiementz J, Longo D, Marshall D, Robichaud KJ. Approaching the controversies in antibacterial management of cancer patients. Am J Med 1984; 76: 436–449
   PubMed Web of Science ®Google Scholar
• Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135: 715–719
   PubMed Web of Science ®Google Scholar
• Solberg CO. Infections in the immunocompromised host. Scand J Infect Dis, Suppl 1980; 24: 36–43
   PubMedGoogle Scholar
• Peltola H, Salomaa T, Sivonen A, Renkonen O-V. Septicemia in a university pediatric hospital: A five-year analysis of the bacterial and fungal isolates and outcome of the infections. Scand J Infect Dis 1987; 19: 277–282
   PubMed Web of Science ®Google Scholar
• Bruun B, Bangsborg J, Hovgaard D, Skinhøj P. Bacteremia and candidemia in hematological malignancies: Microbiological findings and antibiotic susceptibilities. Scand J Infect Dis 1988; 20: 503–509
   PubMed Web of Science ®Google Scholar
• Sjöberg L, Fredlund H. Survey of blood culture isolates in an area of Sweden from 1980 to 1986. Eur J Clin Microbiol Infect Dis 1988; 7: 501–504
   PubMedGoogle Scholar
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton D AG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand, Suppl 1971; 217: 1–90
   Google Scholar
• Swedish Reference Group for Antibiotics. A revised system for antibiotic sensitivity testing. Scand J Infect Dis 1981; 13: 148–152
   PubMedGoogle Scholar
• Dekker AW, Rosenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: A comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987; 106: 7–12
   PubMed Web of Science ®Google Scholar
• Schmeiser T, Kurrle E, Arnold R, Wiesneth M, Bunjes D, Hertenstein B, Kern W, Heit W, Heimpel H. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation. Scand J Infect Dis 1988; 20: 625–631
   PubMed Web of Science ®Google Scholar
• EORTC International Antimicrobial Therapy Project Group. Ceftazidime combined with a short or long coarse of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–1698
   PubMedGoogle Scholar
• Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis—an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503–508
   PubMed Web of Science ®Google Scholar
• Schimpff SC. Infection prevention during profound granulocytopenia—new approaches to alimentary canal microbial suppression. Ann Intern Med 1980; 93: 358–361
   PubMed Web of Science ®Google Scholar
• Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LÅ, Bury J, Ezzedine H, Gigi J, Granlund M, Holm J, Lundberg S, Michaux J-L, Le Sauz N, Wahlin A, Zakrisson E. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: A prospective, randomized multi-clinic study. Scand J Infect Dis, Suppl 1987; 52: 65–78
   PubMedGoogle Scholar
• Young LS. Nosocomial infections in the immunocompromised adult. Am J Med 1981; 70: 398–404
   PubMed Web of Science ®Google Scholar
• Espersen F, Frimodt-Möller N, Thamdrun-Rosdahl V, Jessen O, Faber V, Rosendal K. Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Med Scand 1987; 222: 465–470
   PubMedGoogle Scholar
• Kramer BS, Ramphal R, Rand KH. Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients. Antimi-crob Agents Chemother 1986; 30: 64–68
   PubMed Web of Science ®Google Scholar
• Kramer BS, Ramphal R, Rand KH. Antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1987; 316: 410–411
   PubMedGoogle Scholar
• EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137: 14–29
   PubMed Web of Science ®Google Scholar
• Klastersky J, Meunier-Carpentier F, Prevost JM. Significance of antimicrobial synergism for the outcome of gram negative sepsis. Am J Med Sci 1977; 273: 157–167
   PubMed Web of Science ®Google Scholar
• Bragman S, Sage R, Booth L, Noone P. Ceftazidime in the treatment of serious Pseudomonas aeruginosa sepsis. Scand J Infect Dis 1986; 18: 425–429
   PubMed Web of Science ®Google Scholar
• Swann RA. Successful reduction in the incidence of multiresistance in gram-negative rod-bacteremias in neutropenic patients by withdrawal of ceftazidime. Abstract, 6th Mediterranean Congress of Chemotherapy. TaorminaItaly 22–27 May, 1988
   Google Scholar